PCR (qPCR) was developed and validated, as described in the current study.
Primers for the MYXV qPCR were designed with the Primer3 program 9 to amplify a 147-bp fragment within the serpin (Serp2) gene (accession no. U60474). 8 Viral DNA was extracted from all viral strains, swabs, and fresh and paraffinembedded tissues samples using a commercial kit a following the manufacturer's protocols. In addition, after lysis of fresh and paraffin-embedded tissue, a homogenizer column b was used. Quantitative PCR assays were performed on a thermocycler c with the standard cycle protocol of 2 min at 50°C, 10 min at 95°C, followed by 40 cycles of denaturation at 95°C for 15 sec and annealing at 60°C for 1 min. The MYXV PCR was carried out in 25-µl reactions containing (final concentrations) 12.5 µl of commercial PCR reaction mixture, d 900 nM of each primer (Serp2_For: 5'-GTCGGACGTCTTCGTTTCTC-3'; Serp2_Rev: 5'-ACTCTGGATGCGACGGTTAC-3'), e 250 nM of probe Serp2_Probe (5'-FAM-CGCGCAATTACGTCTC GCCC-TAMRA-3'), e and 7 µl of extracted DNA.
Analytical sensitivity was determined using the standard curve approach. An oligo with a length of 147 bp corresponding to the amplicon size was synthesized e and designated The PCR was tested on paraffin-embedded organ samples from farm, pet, and wild rabbits as well as fresh swab and tissue samples of 4 rabbits j (Table 1) . Further, nasal swabs from healthy Swiss pedigree rabbits of 3 Swiss breeds (Schweizer Fuchs, Schweizer Dreifarben-Kleinschecke, and Schweizer Feh) were taken. k The animals originated from 3 different regions in Switzerland and had not been vaccinated. A total of 12 rabbits from each region (comprised of 3 rabbits of each breed) were tested with the new myxomatosis qPCR.
The analytical sensitivity of the MYXV qPCR was determined using 10-fold dilution series of the Serp2_Oligo. The assay was able to detect 230 copies in 100% and 23 copies in 60% of experiments. Linearity persisted over a range of 10 7 -10 3 copies. The coefficient of determination for the linear regression was 0.9977 (data not shown). The MYXV qPCR was able to detect the 2 MYXV strains tested, while no signal was produced with Rabbit fibroma virus or with Rabbitpox virus. Pasteurella multocida subsp. multocida and B. bronchiseptica were negative.
Swiss field cases of myxomatosis in farm and pet rabbits, as well as in 1 wild rabbit, occurring throughout the country within the last decade were used to test the qPCR in a diagnostic procedure. All of these cases had been confirmed by histology, and all tested positive by qPCR. Three suspicious cases, which were negative in histology, also proved negative by qPCR ( Table 1) . As well, 36 selected nasal swabs of pedigree rabbits were subjected to the MYXV qPCR, and all of them tested negative ( Table 1 ).
The current study shows that the qPCR is able to detect myxomatosis cases in farm, pet, and wild rabbits using swabs and fresh or paraffin-embedded tissues from the last 10 years. Although myxomatosis is infrequently diagnosed in Switzerland (68 cases from 1991 to 2010), spillover from wild rabbit populations and importation of rabbits can provoke new outbreaks. 11 The qPCR developed in the present study simplifies the diagnosis of myxomatosis in clinical cases as well as from fresh or paraffin-embedded tissue samples. Suspicious cases can be quickly affirmed by taking a nasal, ocular, or genital swab. This is also important in the chronic form of myxomatosis, which may not present typical lesions and may be inconclusive in histology. 7, 11 Furthermore, protective measures for flocks in the vicinity of a disease outbreak can be implemented very quickly, such as insect control to prevent spreading by vectors and restriction of animal movements. As the test works well in paraffin-embedded tissue, myxomatosis can also be diagnosed retrospectively from archived samples. Thus, the newly developed assay will be helpful in generating a fast diagnosis for a notifiable disease. 
